KOCAA
Knights of Columbus Asset Advisors’s Viridian Therapeutics VRDN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $811K | Sell |
58,024
-1,257
| -2% | -$17.6K | 0.05% | 256 |
|
|
2025
Q1 | $799K | Buy |
59,281
+1,570
| +3% | +$21.2K | 0.06% | 243 |
|
|
2024
Q4 | $1.11M | Buy |
57,711
+146
| +0.3% | +$2.8K | 0.07% | 236 |
|
|
2024
Q3 | $1.31M | Sell |
57,565
-22,409
| -28% | -$510K | 0.09% | 226 |
|
|
2024
Q2 | $1.04M | Buy |
79,974
+1,152
| +1% | +$15K | 0.07% | 258 |
|
|
2024
Q1 | $1.38M | Sell |
78,822
-75,127
| -49% | -$1.32M | 0.1% | 231 |
|
|
2023
Q4 | $3.35M | Buy |
153,949
+124,396
| +421% | +$2.71M | 0.22% | 195 |
|
|
2023
Q3 | $453K | Buy |
29,553
+823
| +3% | +$12.6K | 0.04% | 272 |
|
|
2023
Q2 | $683K | Buy |
+28,730
| New | +$683K | 0.06% | 263 |
|